Share This Article:

Economic Burden of Infectious Diseases and Benefit of Control and Prevention in Sub-Saharan Africa

DOI: 10.4236/oalib.1102138    819 Downloads   1,736 Views   Citations
Author(s)    Leave a comment

ABSTRACT

Infectious disease is a serious global health problem. However, its negative impact is felt more in sub Saharan Africa. Epidemiological figures have shown that the burden of infectious disease is highest in the African continent especially in sub Saharan Africa. A majority of people leaving in sub Saharan Africa are poor and their exposure to infectious disease worsens their poverty situation. Aside impoverishing infected individuals, infectious diseases also directly negatively impact the economy of the country involved, reducing economic growth and productivity. Diseases like malaria, HIV, tuberculosis TB, and other epidemic prone diseases like Cholera and Ebola constantly pose a threat to economic development in Sub Saharan Africa. It is therefore pertinent to invest in disease prevention strategies to curb the burden and reduce the impact of infectious diseases on the economy of countries in sub Saharan Africa. This mini review re-echoes the burden of infectious diseases and discusses ways and strategies to reduce the burden of these diseases and the economic benefits that will be accrued at the long run.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Orish, V. (2015) Economic Burden of Infectious Diseases and Benefit of Control and Prevention in Sub-Saharan Africa. Open Access Library Journal, 2, 1-6. doi: 10.4236/oalib.1102138.

References

[1] Fonkwo, P.N. (2008) Pricing Infectious Disease: The Economic and Health Implications of Infectious Diseases. EMBO Reports, 9, S13-S17.
http://dx.doi.org/10.1038/embor.2008.110
[2] Young, F., Critchley, J., Johnstone, C. and Unwin, N. (2010) Globalization and the Dual Disease Burden in Sub-Saharan Africa. Diabetes Voice, 55, 30-32.
[3] Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T. and Murray, C.J. (2006) Global and Regional Burden of Disease and Risk Factors, 2001: Systematic Analysis of Population Health Data. The Lancet, 367, 1747-1757.
http://dx.doi.org/10.1016/S0140-6736(06)68770-9
[4] Mathers, C., Fat, D.M. and Boerma, J.T. (2008) The Global Burden of Disease: 2004 Update. World Health Organization, Geneva.
[5] WHO Global Disease Burden (2010) Executive Summary—The Lancet.
http://www.who.int/pmnch/media/news/2012/who_burdenofdisease/en
[6] World Health Organisation Report (2010) Equity, Social Determinants and Public Health Programmes.
http://whqlibdoc.who.int/publications/2010/9789241563970_eng.pdf
[7] Patz, J.A., Githeko, A.K., Mccarty, J.P., Hussein, S., Confalonieri, U. and De Wet, N. (2003) Climate Change and Infectious Diseases. In: Mcmichael, A.J., Campbell-Lendrum, D.H., Corvalán, C.F., Ebi, K.L., Githeko, A.K., Scheraga, J.D. and Woodward, A., Eds., Climate Change and Human Health. Risks and Responses, World Health Organization, Geneva, 103-132.
[8] Jha, P., Chaloupka, F.J., Moore, J., Gajalakshmi, V., Gupta, P.C., Peck, R. and Claeson, M. (2006) Disease Control Priorities in Developing Countries. World Bank Publications, Washington DC.
[9] Plewes, T.J. and Kinsella, K. (2012) The Continuing Epidemiological Transition in Sub-Saharan Africa: A Workshop Summary. National Academies Press, Washington DC
[10] Carapinha, J.L., Ross-Degnan, D., Desta, T.A. and Wagner, K.A. (2010) Health Insurance Systems in Five Sub-Saharan African Countries: Medicine Benefits and Data for Decision Making. Health Policy, 99, 193-202.
[11] WHO (2014) Malaria Facts Sheets.
http://www.who.int/mediacentre/factsheets/fs094/en/
[12] Bull, P.C. and Marsh, K. (2002) The Role of Antibodies to Plasmodium Falciparum-Infected-Erythrocyte Surface Antigens in Naturally Acquired Immunity to Malaria. Trends in Microbiology, 10, 55-58.
http://dx.doi.org/10.1016/S0966-842X(01)02278-8
[13] Snow, R.W., Newton, C.R., Craig, M.H. and Steketee, R.W. (2003) The Public Health Burden of Plasmodium Falciparum Malaria in Africa. Disease Control Priorities Project. Working Paper No. 11, Fogarty International Centre, National Institute of Health, Bethesda.
[14] Gallup, J.L. and Sachs, J.D. (2000) The Economic Burden of Malaria. Center for International Development at Harvard University, Cambridge, MA.
www.cid.harvard.edu
[15] Weiss, R.A. (1993) How Does HIV Cause AIDS? Science, 260, 1273-1279.
http://dx.doi.org/10.1126/science.8493571
[16] WHO (2011) Global Health Sector Strategy on HIV/AIDS 2011-2015. World Health Organisation Report.
http://whqlibdoc.who.int/publications/2011/9789241501651_eng.pdf
[17] WHO (2003) Macro Economics and Health: The Way Forward in the African Region. World Health Organization, Geneva.
[18] WHO (2008) The Burden of Tuberculosis: Economic Burden. World Health Organization, Geneva.
www.who.int
[19] Konstantinos, A. (2010) Testing for Tuberculosis. Australian Prescriber, 33, 12-18.
[20] Lawn, S.D. and Zumla, A.L (2011) Tuberculosis. The Lancet, 378, 57-72.
http://dx.doi.org/10.1016/S0140-6736(10)62173-3
[21] Kim, J.Y., Shakow, A., Castro, A., Vande, C. and Farmer, P. (2008) Tuberculosis Control. World Health Organization, Geneva.
www.who.int
[22] World Health Organization, Global Tuberculosis Programme (1997) Treatment of Tuberculosis: Guidelines for National Programmes. 2nd Edition, World Health Organization, Geneva. Publication WHO/GTB/96.210.
[23] Baron, S. and Finkelstein, R.A. (1996) Cholera, Vibrio cholerae O1 and O139, and Other Pathogenic Vibrios.
[24] Kirigia, J.M., Sambo, L.G., Yokouide, A., Soumbey-Alley, E., Muthuri, L.K. and Kirigia, D.G. (2009) Economic Burden of Cholera in the WHO African Region. BMC International Health and Human Rights, 9, 8.
http://dx.doi.org/10.1186/1472-698X-9-8
[25] Patil, M.S., Patil, M.J., Patil, N.S., Suryawanshi, H.P. and Pawar, S.P. (2015) Review on Ebola Virus Disease.
[26] WHO (2014) Ebola Facts Sheets.
http://www.who.int/mediacentre/factsheets/fs103/en/
[27] World Bank (2014) The Economic Impact of the 2014 Ebola Epidemic: Short- and Medium-Term Estimates for West Africa. World Bank, Washington DC.
[28] WHO (2003) Africa Malaria Report 2003. World Health Organization/UNICEF. WHO/CDC/MAL/2003.
[29] WHO (2000) The African Summit on Roll Back Malaria, Abuja, Nigeria. WHO/CDS/RBM, Geneva.
[30] UNAIDS (2010) UNAIDS Report on the Global AIDS Epidemic. United Nations Programme on HIV/AIDS, Geneva.
[31] Lockwood, D.N. (2002) Emerging Infectious Diseases from the Global to the Local Perspective: A Summary of a Workshop of the Forum on Emerging Infections. Davis, J.R. and Lederberg, J., Eds., Institute of Medicine, National Academy Press, Washington DC, 118 p.
[32] The Guardian News Paper (2014).
http://www.theguardian.com/global-development/poverty-matters/2014/oct/07/nigeria-ebola-experience-teach-world
[33] CDC (2015) Field Epidemiology Training Program.
http://www.cdc.gov/globalhealth/healthprotection/fetp/
[34] Alsan, M.M., Westerhaus, M., Herce, M., Nakashima, K. and Farmer, P.E. (2011) Poverty, Global Health, and Infectious Disease: Lessons from Haiti and Rwanda. Infectious Disease Clinics of North America, 25, 611-622.
http://dx.doi.org/10.1016/j.idc.2011.05.004

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.